Buffett flags inflation, banking risks, criticises speculation, stays heavy on cash, cautious on markets, and says geopolitical tensions and nuclear threats add to global uncertainty.
Nifty’s short-term trend remains weak, as it continues to trade below key moving averages and the March 23 swing low of 22,471.
As the Iran war intensifies, President Donald Trump has prioritised efforts to calm the financial markets — trying to keep oil prices from exploding upward, stocks from cratering and interest rates from surging.
Airtel injects 1 billion dollars into Nxtra, major deals span copper, rail, energy storage, pharma and finance, MakeMyTrip hit by short seller report
Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in India, its second such move, to fend off competition from local drugmakers’ cheaper generics.
Zetwerk files confidential IPO papers aiming to raise up to $550 million at $4 billion valuation, plans listing this year with 300 million in fresh equity
Barclays urges defensive stocks amid market volatility, highlighting Extra Space Storage, JPMorgan, Coca Cola and Merck for dividends and potential upside
Granules India unit gets USFDA VAI rating for Telangana plant after Dec 2025 inspection, no regulatory action, boosting multi site production, shares down slightly
Texmaco Rail wins ₹357.11 crore JSW order to supply wagons and rakes in 11 months, adding to its rail freight order book, shares remain sharply down over recent months
Lupin gets USFDA tentative nod for Sugammadex Injection, a generic of Bridion for reversing surgical muscle relaxants, can launch in US after final approval and exclusivity expiry